EPS

The 3M spin-off navigates a transformative year, posting strong organic growth driven by MedSurg and Dental, despite a reported sales dip from divestitures.

Intelligent power management firm Eaton raises its dividend 6%, backed by record 2025 earnings and a strategic focus on electrification and digitalization.

Stratasys' EcoVadis Gold Medal places it in the top 5% globally, signaling a major shift toward sustainable practices in the additive manufacturing industry.

Perrigo takes a massive $1.3B impairment charge and plans a 7% workforce reduction as it pivots to a 'CORE' business amid a challenging outlook.

The hydration giant posts a 29% revenue jump to $6.7B in its first year, signaling a strong start, but focuses on fixing customer service snags.

The therapy giant reports robust revenue growth and record patient visits, backed by major acquisitions and new 10-year hospital system alliances.

Engineering giant Stantec reports a landmark year with $6.5B revenue, hitting strategic targets early, and raises its dividend, signaling strong future growth.

With a record $411M backlog and surging revenue, Redwire's strategic pivot to defense and space comes at a high cost. Can it turn growth into profit?

Crescent's record production and strategic acquisitions paint a complex picture for investors amid a significant earnings beat but a notable revenue miss.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

The specialty finance giant posted a stunning turnaround, leveraging tech and a hot U.S. market. Here's how it plans to deliver even more in 2026.

The business solutions provider saw record growth in 2025, fueled by client wins, and now plans strategic tech investments while boosting shareholder value.

XPEL reports a massive 50% jump in Q4 net income, yet shares tumble as a revenue miss and a cautious 2026 outlook overshadow the impressive profit growth.

As Wix prepares for a key investor chat, all eyes are on its AI strategy, recent market turbulence, and its path to sustained profitable growth.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.

The bank's Q1 earnings surge to $1.25B, driven by its Canadian Western Bank takeover and strategic deals, signaling aggressive pan-Canadian expansion.

Fresh off record profits, World Gym details its strategy for global growth, betting on AI health platforms and high-margin services to reshape the industry.

The professional information giant posted robust 2025 earnings while ramping up AI investment and navigating a pivotal CEO transition. Here's what it means.

With a 61% profit surge, the Dutch tank storage giant rewards investors while launching a €4B plan to dominate both traditional and green energy infrastructure.

Archrock crushes profit estimates and hikes its dividend, signaling strong confidence as it positions to power the soaring energy demands of LNG and AI.